Market Analysis and Insights: Global Pharmacovigilance (PV) and Drug Safety Software Market
The global Pharmacovigilance (PV) and Drug Safety Software market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Pharmacovigilance (PV) and Drug Safety Software is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Pharmacovigilance (PV) and Drug Safety Software is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Pharmacovigilance (PV) and Drug Safety Software is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key companies of Pharmacovigilance (PV) and Drug Safety Software include AB Cube, Sparta Systems, Inc., Oracle Corporation, EXTEDO GmbH, Ennov Solutions, Inc., ArisGlobal, United BioSource Corporation and Online Business Applications, Inc., etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Pharmacovigilance (PV) and Drug Safety Software market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Pharmacovigilance (PV) and Drug Safety Software, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Pharmacovigilance (PV) and Drug Safety Software, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pharmacovigilance (PV) and Drug Safety Software revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Pharmacovigilance (PV) and Drug Safety Software market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Pharmacovigilance (PV) and Drug Safety Software revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including AB Cube, Sparta Systems, Inc., Oracle Corporation, EXTEDO GmbH, Ennov Solutions, Inc., ArisGlobal, United BioSource Corporation and Online Business Applications, Inc., etc.
By Company
AB Cube
Sparta Systems, Inc.
Oracle Corporation
EXTEDO GmbH
Ennov Solutions, Inc.
ArisGlobal
United BioSource Corporation
Online Business Applications, Inc.
Segment by Type
Cloud based
On-premises
Segment by Application
Pharma and Biotech
Contract Research Organizations (CROs)
Business Process Outsourcing (BPO) Firms
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Pharmacovigilance (PV) and Drug Safety Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmacovigilance (PV) and Drug Safety Software companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmacovigilance (PV) and Drug Safety Software revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmacovigilance (PV) and Drug Safety Software Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Cloud based
1.2.3 On-premises
1.3 Market by Application
1.3.1 Global Pharmacovigilance (PV) and Drug Safety Software Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Pharma and Biotech
1.3.3 Contract Research Organizations (CROs)
1.3.4 Business Process Outsourcing (BPO) Firms
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmacovigilance (PV) and Drug Safety Software Market Perspective (2018-2029)
2.2 Global Pharmacovigilance (PV) and Drug Safety Software Growth Trends by Region
2.2.1 Pharmacovigilance (PV) and Drug Safety Software Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Pharmacovigilance (PV) and Drug Safety Software Historic Market Size by Region (2018-2023)
2.2.3 Pharmacovigilance (PV) and Drug Safety Software Forecasted Market Size by Region (2024-2029)
2.3 Pharmacovigilance (PV) and Drug Safety Software Market Dynamics
2.3.1 Pharmacovigilance (PV) and Drug Safety Software Industry Trends
2.3.2 Pharmacovigilance (PV) and Drug Safety Software Market Drivers
2.3.3 Pharmacovigilance (PV) and Drug Safety Software Market Challenges
2.3.4 Pharmacovigilance (PV) and Drug Safety Software Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Pharmacovigilance (PV) and Drug Safety Software by Players
3.1.1 Global Pharmacovigilance (PV) and Drug Safety Software Revenue by Players (2018-2023)
3.1.2 Global Pharmacovigilance (PV) and Drug Safety Software Revenue Market Share by Players (2018-2023)
3.2 Global Pharmacovigilance (PV) and Drug Safety Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Pharmacovigilance (PV) and Drug Safety Software, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Pharmacovigilance (PV) and Drug Safety Software Market Concentration Ratio
3.4.1 Global Pharmacovigilance (PV) and Drug Safety Software Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmacovigilance (PV) and Drug Safety Software Revenue in 2022
3.5 Global Key Players of Pharmacovigilance (PV) and Drug Safety Software Head office and Area Served
3.6 Global Key Players of Pharmacovigilance (PV) and Drug Safety Software, Product and Application
3.7 Global Key Players of Pharmacovigilance (PV) and Drug Safety Software, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmacovigilance (PV) and Drug Safety Software Breakdown Data by Type
4.1 Global Pharmacovigilance (PV) and Drug Safety Software Historic Market Size by Type (2018-2023)
4.2 Global Pharmacovigilance (PV) and Drug Safety Software Forecasted Market Size by Type (2024-2029)
5 Pharmacovigilance (PV) and Drug Safety Software Breakdown Data by Application
5.1 Global Pharmacovigilance (PV) and Drug Safety Software Historic Market Size by Application (2018-2023)
5.2 Global Pharmacovigilance (PV) and Drug Safety Software Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Pharmacovigilance (PV) and Drug Safety Software Market Size (2018-2029)
6.2 North America Pharmacovigilance (PV) and Drug Safety Software Market Size by Type
6.2.1 North America Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2018-2023)
6.2.2 North America Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2024-2029)
6.2.3 North America Pharmacovigilance (PV) and Drug Safety Software Market Share by Type (2018-2029)
6.3 North America Pharmacovigilance (PV) and Drug Safety Software Market Size by Application
6.3.1 North America Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2018-2023)
6.3.2 North America Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2024-2029)
6.3.3 North America Pharmacovigilance (PV) and Drug Safety Software Market Share by Application (2018-2029)
6.4 North America Pharmacovigilance (PV) and Drug Safety Software Market Size by Country
6.4.1 North America Pharmacovigilance (PV) and Drug Safety Software Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Pharmacovigilance (PV) and Drug Safety Software Market Size by Country (2018-2023)
6.4.3 North America Pharmacovigilance (PV) and Drug Safety Software Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Pharmacovigilance (PV) and Drug Safety Software Market Size (2018-2029)
7.2 Europe Pharmacovigilance (PV) and Drug Safety Software Market Size by Type
7.2.1 Europe Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2018-2023)
7.2.2 Europe Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2024-2029)
7.2.3 Europe Pharmacovigilance (PV) and Drug Safety Software Market Share by Type (2018-2029)
7.3 Europe Pharmacovigilance (PV) and Drug Safety Software Market Size by Application
7.3.1 Europe Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2018-2023)
7.3.2 Europe Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2024-2029)
7.3.3 Europe Pharmacovigilance (PV) and Drug Safety Software Market Share by Application (2018-2029)
7.4 Europe Pharmacovigilance (PV) and Drug Safety Software Market Size by Country
7.4.1 Europe Pharmacovigilance (PV) and Drug Safety Software Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Pharmacovigilance (PV) and Drug Safety Software Market Size by Country (2018-2023)
7.4.3 Europe Pharmacovigilance (PV) and Drug Safety Software Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Pharmacovigilance (PV) and Drug Safety Software Market Size (2018-2029)
8.2 China Pharmacovigilance (PV) and Drug Safety Software Market Size by Type
8.2.1 China Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2018-2023)
8.2.2 China Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2024-2029)
8.2.3 China Pharmacovigilance (PV) and Drug Safety Software Market Share by Type (2018-2029)
8.3 China Pharmacovigilance (PV) and Drug Safety Software Market Size by Application
8.3.1 China Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2018-2023)
8.3.2 China Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2024-2029)
8.3.3 China Pharmacovigilance (PV) and Drug Safety Software Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Pharmacovigilance (PV) and Drug Safety Software Market Size (2018-2029)
9.2 Asia Pharmacovigilance (PV) and Drug Safety Software Market Size by Type
9.2.1 Asia Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2018-2023)
9.2.2 Asia Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2024-2029)
9.2.3 Asia Pharmacovigilance (PV) and Drug Safety Software Market Share by Type (2018-2029)
9.3 Asia Pharmacovigilance (PV) and Drug Safety Software Market Size by Application
9.3.1 Asia Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2018-2023)
9.3.2 Asia Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2024-2029)
9.3.3 Asia Pharmacovigilance (PV) and Drug Safety Software Market Share by Application (2018-2029)
9.4 Asia Pharmacovigilance (PV) and Drug Safety Software Market Size by Region
9.4.1 Asia Pharmacovigilance (PV) and Drug Safety Software Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Pharmacovigilance (PV) and Drug Safety Software Market Size by Region (2018-2023)
9.4.3 Asia Pharmacovigilance (PV) and Drug Safety Software Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Pharmacovigilance (PV) and Drug Safety Software Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Pharmacovigilance (PV) and Drug Safety Software Market Size by Type
10.2.1 Middle East, Africa, and Latin America Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Pharmacovigilance (PV) and Drug Safety Software Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Pharmacovigilance (PV) and Drug Safety Software Market Size by Application
10.3.1 Middle East, Africa, and Latin America Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Pharmacovigilance (PV) and Drug Safety Software Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Pharmacovigilance (PV) and Drug Safety Software Market Size by Country
10.4.1 Middle East, Africa, and Latin America Pharmacovigilance (PV) and Drug Safety Software Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Pharmacovigilance (PV) and Drug Safety Software Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Pharmacovigilance (PV) and Drug Safety Software Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 AB Cube
11.1.1 AB Cube Company Details
11.1.2 AB Cube Business Overview
11.1.3 AB Cube Pharmacovigilance (PV) and Drug Safety Software Introduction
11.1.4 AB Cube Revenue in Pharmacovigilance (PV) and Drug Safety Software Business (2018-2023)
11.1.5 AB Cube Recent Developments
11.2 Sparta Systems, Inc.
11.2.1 Sparta Systems, Inc. Company Details
11.2.2 Sparta Systems, Inc. Business Overview
11.2.3 Sparta Systems, Inc. Pharmacovigilance (PV) and Drug Safety Software Introduction
11.2.4 Sparta Systems, Inc. Revenue in Pharmacovigilance (PV) and Drug Safety Software Business (2018-2023)
11.2.5 Sparta Systems, Inc. Recent Developments
11.3 Oracle Corporation
11.3.1 Oracle Corporation Company Details
11.3.2 Oracle Corporation Business Overview
11.3.3 Oracle Corporation Pharmacovigilance (PV) and Drug Safety Software Introduction
11.3.4 Oracle Corporation Revenue in Pharmacovigilance (PV) and Drug Safety Software Business (2018-2023)
11.3.5 Oracle Corporation Recent Developments
11.4 EXTEDO GmbH
11.4.1 EXTEDO GmbH Company Details
11.4.2 EXTEDO GmbH Business Overview
11.4.3 EXTEDO GmbH Pharmacovigilance (PV) and Drug Safety Software Introduction
11.4.4 EXTEDO GmbH Revenue in Pharmacovigilance (PV) and Drug Safety Software Business (2018-2023)
11.4.5 EXTEDO GmbH Recent Developments
11.5 Ennov Solutions, Inc.
11.5.1 Ennov Solutions, Inc. Company Details
11.5.2 Ennov Solutions, Inc. Business Overview
11.5.3 Ennov Solutions, Inc. Pharmacovigilance (PV) and Drug Safety Software Introduction
11.5.4 Ennov Solutions, Inc. Revenue in Pharmacovigilance (PV) and Drug Safety Software Business (2018-2023)
11.5.5 Ennov Solutions, Inc. Recent Developments
11.6 ArisGlobal
11.6.1 ArisGlobal Company Details
11.6.2 ArisGlobal Business Overview
11.6.3 ArisGlobal Pharmacovigilance (PV) and Drug Safety Software Introduction
11.6.4 ArisGlobal Revenue in Pharmacovigilance (PV) and Drug Safety Software Business (2018-2023)
11.6.5 ArisGlobal Recent Developments
11.7 United BioSource Corporation
11.7.1 United BioSource Corporation Company Details
11.7.2 United BioSource Corporation Business Overview
11.7.3 United BioSource Corporation Pharmacovigilance (PV) and Drug Safety Software Introduction
11.7.4 United BioSource Corporation Revenue in Pharmacovigilance (PV) and Drug Safety Software Business (2018-2023)
11.7.5 United BioSource Corporation Recent Developments
11.8 Online Business Applications, Inc.
11.8.1 Online Business Applications, Inc. Company Details
11.8.2 Online Business Applications, Inc. Business Overview
11.8.3 Online Business Applications, Inc. Pharmacovigilance (PV) and Drug Safety Software Introduction
11.8.4 Online Business Applications, Inc. Revenue in Pharmacovigilance (PV) and Drug Safety Software Business (2018-2023)
11.8.5 Online Business Applications, Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
AB Cube
Sparta Systems, Inc.
Oracle Corporation
EXTEDO GmbH
Ennov Solutions, Inc.
ArisGlobal
United BioSource Corporation
Online Business Applications, Inc.
*If Applicable.